Literature DB >> 24043493

Retooling the pap smear for ovarian and endometrial cancer detection.

Jamie Bakkum-Gamez1, Sean Dowdy.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24043493      PMCID： PMC4077279          DOI： 10.1373/clinchem.2013.204933

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

Authors:  Tim Forshew; Muhammed Murtaza; Christine Parkinson; Davina Gale; Dana W Y Tsui; Fiona Kaper; Sarah-Jane Dawson; Anna M Piskorz; Mercedes Jimenez-Linan; David Bentley; James Hadfield; Andrew P May; Carlos Caldas; James D Brenton; Nitzan Rosenfeld
Journal:  Sci Transl Med       Date:  2012-05-30       Impact factor: 17.956

2.  Methylated DNA collected by tampons--a new tool to detect endometrial cancer.

Authors:  Heidi Fiegl; Conny Gattringer; Andreas Widschwendter; Alois Schneitter; Angela Ramoni; Daniela Sarlay; Inge Gaugg; Georg Goebel; Hannes M Müller; Elisabeth Mueller-Holzner; Christian Marth; Martin Widschwendter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-05       Impact factor: 4.254

3.  Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.

Authors:  Isaac Kinde; Chetan Bettegowda; Yuxuan Wang; Jian Wu; Nishant Agrawal; Ie-Ming Shih; Robert Kurman; Fanny Dao; Douglas A Levine; Robert Giuntoli; Richard Roden; James R Eshleman; Jesus Paula Carvalho; Suely Kazue Nagahashi Marie; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

4.  Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

Authors:  Patricia A Shaw; Marjan Rouzbahman; Ellen S Pizer; Melania Pintilie; Heather Begley
Journal:  Mod Pathol       Date:  2009-06-19       Impact factor: 7.842

5.  The preclinical natural history of serous ovarian cancer: defining the target for early detection.

Authors:  Patrick O Brown; Chana Palmer
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069
  5 in total
  4 in total

1.  Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).

Authors:  Elisabeth Luporsi; Alain Toledano; Dominique Spaeth; Florian Scotté; Marc Espié; Stéphanie Perot; Ladan Duvillié; Isabelle Pithois Merli; Roland Bugat
Journal:  Support Care Cancer       Date:  2016-12-03       Impact factor: 3.603

2.  Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma.

Authors:  Jeffrey D Krimmel-Morrison; Talayeh S Ghezelayagh; Shenyi Lian; Yuezheng Zhang; Jeanne Fredrickson; Daniela Nachmanson; Kathryn T Baker; Marc R Radke; Enna Hun; Barbara M Norquist; Mary J Emond; Elizabeth M Swisher; Rosa Ana Risques
Journal:  Gynecol Oncol       Date:  2019-12-12       Impact factor: 5.482

Review 3.  Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.

Authors:  Rongrong Huang; Zhongsi Chen; Lei He; Nongyue He; Zhijiang Xi; Zhiyang Li; Yan Deng; Xin Zeng
Journal:  Theranostics       Date:  2017-08-18       Impact factor: 11.556

4.  Ovarian cancer detection by DNA methylation in cervical scrapings.

Authors:  Tzu-I Wu; Rui-Lan Huang; Po-Hsuan Su; Shih-Peng Mao; Chen-Hsuan Wu; Hung-Cheng Lai
Journal:  Clin Epigenetics       Date:  2019-11-27       Impact factor: 6.551
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.